Attitudes Toward Buprenorphine and Methadone Among Opioid‐Dependent Individuals

Overview of attention for article published in American Journal on Addictions, February 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 3 policy sources

reddit: 1 Redditor

Readers on

mendeley: 84 Mendeley

So far, Altmetric has seen 4 policy documents that reference this research output.

Spatial proximity and access to buprenorphine or methadone treatment for opioid use disorder in a sample of people misusing opioids in Southern California

Cited by Centers for Disease Control and Prevention (CDC) on 29 Aug 2023

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida

Cited by Centers for Disease Control and Prevention (CDC) on 01 Apr 2021

Implementing methadone maintenance treatment in prisons in Malaysia

Cited by World Health Organization (WHO) on 01 Feb 2013

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Injectable Extended-Release Naltrexone to Treat Opioid Use Disorder

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 31 May 2011

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.